Skip to content
lifestyle.childcarepartnerships.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
Kalohexis
Kalohexis Appoints Thomas Forest Farb-Horch to Board of Directors
September 22, 2026
Kalohexis Appoints Garry Menzel, Ph.D., to Board of Directors
September 1, 2026
Kalohexis Appoints Life Sciences Leader, Jeffrey Sherman, MD, to Board of Directors
August 11, 2026
Kalohexis Appoints Xuan Hui, B.Med., M.S., Ph.D., as Director of Corporate Strategy
June 18, 2026
Kalohexis Presents Data Highlighting Dual MC3R/MC4R Activation as a Novel Mechanism Designed to Drive Safer, Healthier and More Durable Weight Loss at ENDO 2026
June 15, 2026
Kalohexis Announces Publication in Nature Communications Highlighting Dual MC3R/MC4R Activation as a Novel, Durable Mechanism that Drives Weight Loss
May 29, 2026
Kalohexis Announces First Patients Dosed in First-in-Human Phase 1 Clinical Trial of 710GO for General Obesity
May 28, 2026
Kalohexis Announces Poster Presentation at the American Association for Cancer Research Annual Meeting 2026
April 17, 2026
Kalohexis Appoints Tony Mitchell as Chief Financial Officer
March 31, 2026